Clik here to view.
крисаборол , كريسابورول , Crisaborole, AN 2728
Crisaborole Treatment for Inflammatory Skin Diseases, including Atopic Dermatitis and Psoriasis C14H10BNO3, Average mass251.045 Da 4-[(1-Hydroxy-1,3-dihydro-2,1-benzoxaborol-5-yl)oxy]benzonitrile ,...
View ArticleClik here to view.
Mirogabalin
Mirogabalin, A-2000700, DS-5565 1138245-13-2, C12H19NO2, 209.28 [(1R,5S,6S)-6-(aminomethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl]acetic acid...
View ArticleClik here to view.
Tesmilifene , Antagonist of intracellular histamine
Tesmilifene BMS-217380; BMY-33419; DPPE CAS No. 98774-23-3(Tesmilifene), 92981-78-7(Tesmilifene hydrochloride) Tesmilifene CAS 98774-23-3 N,N-Diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine DPPE...
View ArticleClik here to view.
Lusutrombopag….Oral thrombopoietin (TPO) mimetic
Lusutrombopag (E)-3-[2,6-dichloro-4-[[4-[3-[(1S)-1-hexoxyethyl]-2-methoxyphenyl]-1,3-thiazol-2-yl]carbamoyl]phenyl]-2-methylprop-2-enoic acid...
View ArticleClik here to view.
MK 7655, RELEBACTAM, a β-Lactamase inhibitor
MK 7655, RELEBACTAM (1R,2S,5R)-7-Oxo-N-(4-piperidinyl)-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide (1R,2S,5R)-7-oxo-2-((piperidin-4-yl)carbamoyl)-1,6-diazabicyclo(3.2.1)octan-6-yl...
View ArticleClik here to view.
MELOGLIPTIN
Melogliptin Phase III A DP-IV inhibitor potentially for treatment of type II diabetes. EMD-675992; GRC-8200 CAS No. 868771-57-7...
View ArticleClik here to view.
TEVA’S CEP 1347, KT 7515 a MAP3K11 (MLK3) inhibitor potentially for the...
CEP-1347; KT-7515 CAS. 156177-65-0 Cephalon Inc, Kyowa Hakko Kogyo Kk WO2000013015...
View ArticleClik here to view.
GS 9883, Bictegravir an HIV-1 integrase inhibitor
GS 9883, bictegravir CAS 1611493-60-7 PHASE 3 HIV-1 integrase inhibitor...
View ArticleClik here to view.
CE-224535 for the treatment of rheumatoid arthritis and osteoarthritis
CE-224535 2-(4-Chloro-3-(3-(1-hydroxycycloheptyl)propanoyl)phenyl)-4-((2R)-2-hydroxy-3-methoxy-propyl)-1,2,4-triazine-3,5-dione Benzamide,...
View ArticleClik here to view.
Dofequidar fumarate
Dofequidar fumarate Phase III A P-glycoprotein inhibitor potentially for the treatment of breast cancer and non-small lung cancer (NSCLC). MS-209; Dofequidar fumarate CAS No. 129716-58-1 (Dofequidar...
View ArticleClik here to view.
Ponalrestat
Ponalrestat Phase III An aldose reductase inhibitor potentially for the treatment of diabetes. Imperial Chemical Industries Limited innovator ICI-128436; MK-538; ICI-plc CAS No.72702-95-5 Statil;...
View ArticleClik here to view.
Talazoparib, BMN 673
Talazoparib, BMN-673, MDV-3800 (2S,3S)-methyl-7-fluoro-2-(4-fluorophenyl)-3-(1-methyl-1H-1,2,4-triazol-5-yl)-4-oxo-1,2,3,4-tetrahydroquinoline-5-carboxylate...
View ArticleClik here to view.
Finerenone, BAY 94-8862
Finerenone Finerenone; UNII-DE2O63YV8R; BAY 94-8862; DE2O63YV8R; 1050477-31-0 C21H22N4O3 MW 378.42438 g/mol...
View ArticleClik here to view.
ILAPRAZOLE, IY-81149
Ilaprazole cas 172152-36-2; Iy 81149; IY-81149; 2-{[(4-methoxy-3-methylpyridin-2-yl)methyl]sulfinyl}-6-(1h-pyrrol-1-yl)-1h-benzimidazole; Aldenon; MW 366.437, MF C19 H18 N4 O2 S...
View ArticleClik here to view.
ODM-201
ODM 201, BAY 1841788; ODM-201 N-((S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide CAS 1297538-32-9 Chemical Formula: C19H19ClN6O2 Exact...
View ArticleClik here to view.
Tripeptide Glycyl-L-Prolyl-L-Glutamate (Gly-Pro-Glu or GPE)
Gly-Pro-Glu Synonym: GPE, Glycyl-prolyl-glutamic acid, (1-3)IGF-1 Pfizer (Originator) Neuren Pharmaceuticals (Originator) Glypromate; glycine-proline-glutamate (neuroprotectant), Neuren CAS Number...
View ArticleClik here to view.
Galunisertib
Galunisertib Phase III A TGF-beta receptor type-1 inhibitor potentially for the treatment of myelodysplastic syndrome (MDS) and solid tumours. LY-2157299 CAS No.700874-72-2...
View ArticleClik here to view.
Rovatirelin Hydrate
Rovatirelin Hydrate, S-0373, Rovatirelin, RN: 204386-76-5 UNII: 9DL0X410PY...
View ArticleClik here to view.
Clik here to view.
Gilteritinib for Treatment of Acute Myeloid Leukemia
Gilteritinib ASP-2215 Treatment of Acute Myeloid Leukemia 6-ethyl-3-{3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino}-5-[(oxan-4-yl)amino]pyrazine-2-carboxamide C29H44N8O3, 552.71 Phase...
View Article